News
Analysts are estimating that Novavax will report an earnings per share (EPS) of $0.19. The market awaits Novavax's ...
Novavax, Inc. (Nasdaq: NVAX) today announced that it will participate in the BofA Securities 2025 Health Care Conference.
12h
Zacks Investment Research on MSNNiagen Bioscience (NAGE) Q1 Earnings and Revenues Beat EstimatesNiagen Bioscience (NAGE) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.02 per share. This compares to loss of $0.01 per share a year ago. These ...
Nasdaq provides visual representation of analyst expected earnings growth. Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the ...
FDA names Vinay Prasad to lead CBER, raising questions over biologics oversight and triggering biotech stock losses and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results